Association of Life's Essential 8 and Life's Simple 7 with metabolic-associated fatty liver disease in the United States.

Background: Cardiovascular health (CVH) plays a crucial role in overall health, but its association with metabolic-associated fatty liver disease (MAFLD) remains unclear.

Aim: To investigate the relationship between CVH, measured using Life's Essential 8 (LE8) and Life's Simple 7 (LS7), and the prevalence of MAFLD.

Methods: This cross-sectional study had a sample of 2234 individuals, representing approximately 120 million individuals in the United States.

Dietary Inflammatory index and its association with fatty liver disease: a study in obese and non-obese populations.

Background: The worldwide incidence of non-alcoholic fatty liver disease (NAFLD) is a pressing health issue, with chronic inflammation critically influencing its development. The Dietary Inflammatory Index (DII) measures the inflammatory potential of one's diet. Our study aimed to investigate the association between DII and fatty liver disease in obese and non-obese individuals.

RNA splicing of the STAT3 by PCBP1 promotes vulnerable plaque formation via macrophage-like phenotype modulation of vascular smooth muscle cell.

Background: The increase of macrophage-like vascular smooth muscle cells (VSMCs) within atherosclerotic plaques significantly contributes to plaque vulnerability. The STAT3 signaling is crucial in maintaining the contractile phenotype of VSMCs. Recent studies have identified two isoforms of STAT3, STAT3α and STAT3β, generated through alternative splicing.

Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma.

Kidney clear cell renal cell carcinoma (KIRC) is also the most lethal subtype among all kidney cancer subtypes, posing a severe threat to public health. Therefore, it is crucial to identify new, reliable biomarkers in KIRC. Therefore, it is crucial to identify novel, reliable biomarkers associated with KIRC.

Families' perception of terminal patients' prognosis awareness is associated with families' own grief: Evidence from a hospital in China.

Aim: The aim of the study was to explore how families' perceptions of dying patients' prognosis awareness influence families' grief.

Design: A cross-sectional design was adopted.

Method: Data were collected from a survey of family caregivers of deceased patients through a tertiary hospital in Mainland China between October 2018 and April 2021.

Information disclosure to cancer patients in Mainland China: A meta-analysis.

Objective: This study aims to systematically examine Chinese cancer patients' and families' preferences for information disclosure to the patient, patient awareness, and predictors of patient awareness.

Methods: The Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed. Web of Science, Scopus, Proquest, Taylor & Francis Online, and China National Knowledge Infrastructure were searched in April 2022 and Chinese Biomedical Literature Database in July 2022 for quantitative studies.

End-of-Life Needs of Dying Patients and Their Families in Mainland China: A Systematic Review.

Objective: To map the current research status and understand existing findings regarding end-of-life care needs in Mainland China.

Method: First-hand, empirical studies on the needs of dying patients and/or their families in Mainland China were searched in Web of Science, Scopus, Proquest, Taylor & Francis Online and CNKI in December 2019. Findings were synthesized.

Circulating lncRNA BC030099 Increases in Preeclampsia Patients.

Long noncoding RNAs (lncRNAs) have increasingly been shown to be important biological regulators involved in numerous diseases. Further, increasing evidence demonstrates that circulating lncRNAs can be used as diagnostic biomarkers. Therefore, the purpose of this study was to evaluate the potential for circulating lncRNAs as novel biomarkers for the diagnosis of preeclampsia.